| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 10.03. | Novo Nordisk Reaches Deal with Hims & Hers to Expand Access to Ozempic, Wegovy | ||
| 10.03. | Colbert Packaging Invests in New Eterna Blanking Die Cutter | ||
| 09.03. | FDA Approves BMS' Sotyktu for Active Psoriatic Arthritis Treatment | ||
| 09.03. | NorthX Biologics, Demeetra Partner on Integrated Path from Gene to GMP | ||
| 09.03. | Bausch + Lomb, Steriline Enter Sterile Ophthalmic Manufacturing Pact | ||
| 09.03. | AstraZeneca's Enhertu Gets Priority Review from FDA for HER2-Positive Breast Cancer | ||
| 09.03. | Neuland Labs to Add Commercial Peptide Capacity with New India Facility in 2026 | ||
| 09.03. | Kindeva Appoints Mike Cowhig as Chief Legal Officer | ||
| 09.03. | Spruce Biosciences Appoints Dale Hooks as Chief Commercial Officer | ||
| 09.03. | Lonza, Genetix Bio Extend Commercial Mfg. Pact for ZYNTEGLO | ||
| 09.03. | NewcelX, Eledon Partner to Advance a Potential Functional Cure for Type 1 Diabetes | ||
| 06.03. | Lonza Divests Capsules & Health Ingredients Biz | ||
| 06.03. | Servier Acquires Day One Biopharmaceuticals, Expanding Rare Oncology Portfolio | ||
| 06.03. | Thermo Fisher Opens Bay Area Cryo-EM Drug Discovery Center | ||
| 06.03. | Nicoya Lifesciences Launches Mass Spectrometry Platform to Measure Protein Dynamics | ||
| 06.03. | Coating Place Updates Leadership and Launches New OSD Packaging Line | ||
| 06.03. | Forma Life Sciences Launches U.S. Based CDMO | ||
| 06.03. | Johnson & Johnson's TECVAYLI plus DARZALEX FASPRO Approved by FDA for RRMM | ||
| 05.03. | SmartSkin Technologies Introduces Seal Assurance Solution | ||
| 05.03. | Invivyd Names Michael Mina Chief Medical Officer | ||
| 05.03. | Frontage Labs Completes Acquisition of Teddy Lab | ||
| 05.03. | Novartis to Build New Radioligand Therapy Site in Denton, Texas | ||
| 05.03. | Arcutis Promotes Mas Matsuda to Executive Vice President, Chief Legal Officer | ||
| 05.03. | Upperton Seeks MHRA Approval for New Sterile Manufacturing Facility | ||
| 05.03. | Therna Biosciences, Charles River Partner to Advance Single-Patient RNA Medicines |